Literature DB >> 20425278

Catatonia: diagnosis, classification, and treatment.

Andrew Francis1.   

Abstract

Catatonia is a distinct neuropsychiatric syndrome that is becoming more recognized clinically and in ongoing research. It occurs with psychiatric, metabolic, or neurologic conditions. It may occur in many forms, including neuroleptic malignant syndrome. Treatment with benzodiazepines or electroconvulsive therapy leads to a dramatic and rapid response, although systematic, randomized trials are lacking. An important unresolved question is the role of antipsychotic agents in treatment and their potential adverse effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425278     DOI: 10.1007/s11920-010-0113-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  32 in total

1.  Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.

Authors:  G S Ungvari; H F Chiu; L Y Chow; B S Lau; W K Tang
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

2.  An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms.

Authors:  F Martényi; S Metcalfe; B Schausberger; M R Dossenbach
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  The catatonia rating scale I--development, reliability, and use.

Authors:  P Bräunig; S Krüger; G Shugar; J Höffler; I Börner
Journal:  Compr Psychiatry       Date:  2000 Mar-Apr       Impact factor: 3.735

4.  Catatonia and other motor syndromes in a chronically hospitalized psychiatric population.

Authors:  G Bush; G Petrides; A Francis
Journal:  Schizophr Res       Date:  1997-10-17       Impact factor: 4.939

5.  Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.

Authors:  H Wetzel; I Heuser; O Benkert
Journal:  J Nerv Ment Dis       Date:  1987-04       Impact factor: 2.254

Review 6.  Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.

Authors:  Brendan T Carroll; Harold W Goforth; Christopher Thomas; Niraj Ahuja; William W McDaniel; Marilyn F Kraus; David R Spiegel; Kathleen N Franco; Leopold Pozuelo; Camilo Muñoz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

Review 7.  Catatonia in autism: implications across the life span.

Authors:  Angelina Kakooza-Mwesige; Lee E Wachtel; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

8.  Catatonia and consultation-liaison psychiatry study of 12 cases.

Authors:  Olivier Cottencin; Frédérique Warembourg; Marie Bérengère de Chouly de Lenclave; Bernard Lucas; Guillaume Vaiva; Michel Goudemand; Pierre Thomas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-04-19       Impact factor: 5.067

9.  Catatonia in depression: prevalence, clinical correlates, and validation of a scale.

Authors:  S E Starkstein; G Petracca; A Tesón; E Chemerinski; M Merello; R Migliorelli; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

10.  Idiopathic catatonia: validity of the concept.

Authors:  V Benegal; S Hingorani; S Khanna
Journal:  Psychopathology       Date:  1993       Impact factor: 1.944

View more
  22 in total

Review 1.  Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis.

Authors:  Arnaud Leroy; Florian Naudet; Guillaume Vaiva; Andrew Francis; Pierre Thomas; Ali Amad
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-21       Impact factor: 5.270

2.  Catatonia in resource-limited settings: a case series and treatment protocol.

Authors:  Stephanie L Smith; David J Grelotti; Reginald Fils-Aime; Eugenie Uwimana; Jean-Sauveur Ndikubwimana; Tatiana Therosme; Jennifer Severe; Dominique Dushimiyimana; Clemence Uwamariya; Robert Bienvenu; Yoldie Alcindor; Eddy Eustache; Giuseppe J Raviola; Gregory L Fricchione
Journal:  Gen Hosp Psychiatry       Date:  2014-10-30       Impact factor: 3.238

3.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

4.  Status of psychotic disorders in ICD-11.

Authors:  Wolfgang Gaebel
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

5.  Diagnosis and management of periodic catatonia.

Authors:  William M Hervey; Jonathan T Stewart; Glenn Catalano
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

6.  Brief episodes of non-specific psychosis later diagnosed as periodic catatonia.

Authors:  Victor Mark Tang; Helen Park
Journal:  BMJ Case Rep       Date:  2016-11-22

Review 7.  Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

Authors:  Federica Luchini; Pierpaolo Medda; Michela Giorgi Mariani; Mauro Mauri; Cristina Toni; Giulio Perugi
Journal:  World J Psychiatry       Date:  2015-06-22

8.  The Wandering Woman: A Case Study of Catatonia vs Factitious Disorder.

Authors:  Jennifer Wh Wong; Steven R Williams
Journal:  Hawaii J Med Public Health       Date:  2017-03

9.  Catatonia in a 6-year-old Patient Following Disseminated Group A Streptococcus Infection.

Authors:  Philip B Cawkwell; Ivan Daniel Mayor; Richard J Shaw
Journal:  Innov Clin Neurosci       Date:  2021-01-01

10.  Enhanced Automatic Action Imitation and Intact Imitation-Inhibition in Schizophrenia.

Authors:  Arndis Simonsen; Riccardo Fusaroli; Joshua Charles Skewes; Andreas Roepstorff; Daniel Campbell-Meiklejohn; Ole Mors; Vibeke Bliksted
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.